To examine the efficacy of atypical neuroleptics for decreasing craving and drug relapses during protracted withdrawal in individuals dually diagnosed with schizophrenia and cocaine dependence.
Method:
We conducted a 6-week, open-label pilot study comparing risperidone with typical neuroleptics in a sample of withdrawn cocaine-dependent schizophrenia patients.
Results:
Preliminary results suggest that individuals treated with risperidone had significantly less cue-elicited craving and substance abuse relapses at study completion. Further, they showed a trend toward a greater reduction in negative and global symptoms of schizophrenia.
Conclusion:
Atypical neuroleptics may help reduce craving and relapses in this population. Future research should include more rigorous double-blind placebo-controlled studies with this class of medications.
RegierDAFarmerMERaeDSLockeBZKeithSJJuddLL, and others. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA1990;264:2511–8.
2.
ZiedonisDMFisherW.Assessment and treatment of comorbid substance abuse in individuals with schizophrenia. Psychiatr Ann1994;24:477–83.
3.
ZiedonisDMTrudeauK.Motivation to quit using substances among individuals with schizophrenia. Schizophr Bull1997;23:229–38.
4.
LysakerPBellMBeam GouletMSMilsteinR.Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment Dis1994;182:109–12.
5.
ZiedonisDMRichardsonTLeeTPetrakisIKostenT.Adjunctive disipramine in the treatment of cocaine abusing schizoiphrenics. Psychopharmacology Bulletin1992;3:309–14.
6.
SerperMRAlpertMRichardsonNADicksonSAllenMAWernerA.Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry1995;152:1464–9.
7.
DavisKLKahnRSKoGDavidsonM.Dopamine in schizophrenia: A review and reconceptualization. Am J Psychiatry1991;148:1474–86.
8.
SeemanPBzowejNHGuanHCBergeronCReynoldsGPBirdED, and others. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases. Neuropsychopharmacology1987;1(1):5–15.
9.
MarkouAWeissFGoldLHCaineSBSchulteisGKoobGF. Animal models of drug craving. Psychopharmacology1993;112:163–82.
10.
SmelsonDARoyARoyMTorshekovicDEngelhartCLosonczyM.F.Electroretinogram and cue-elicited craving in withdrawn cocaine dependent patients: A replication. American Journal of Drug and Alcohol Dependence2001;27:391–7.
11.
SmelsonDALosonczyMKilkerCStarostaAKindJWilliamsJZiedonisD.An analysis of cue-reactivity among individuals with schizophrenia compared to cocaine addicts without schizophrenia. Psychiatric Services2002. Forthcoming.
12.
CarolGSmelsonDAStarostaALosonczyMFZiedonisD.Alcohol and drug abuse: A preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv2001;52(8):1029–32.
13.
BergerSHallSMickalianJReidMSCrawfordCADelicchiK, and others. Halperidol antagonism of cue-elicited cocaine craving. Lancet1996;347:504–8.
14.
GawanFAllenDHumblestoneB.Outpatient treatment of crack-cocaine smoking with fluphenthixol decanoate: A preliminary report. Arch Gen Psychiatry1989;46:322–5.
15.
LevinFREvansSMCoomaraswammySCollinsEDRegentNKleberHD. Flupenthixol treatment for cocaine abusers with schizophrenia: A pilot study. Am J Drug Alcohol Abuse1998;24:343–60.
16.
Buydens-BracheyLBracheyMFergesonM AHudsonJMcKerninC.Craving for cocaine in addicted users. American Journal of Addictions1996; 6(1):65–73.
17.
BuckleyP.Novel antipyschotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat1998;15:113–6.
18.
YovellYOplerLA. Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abusers: Case report and hypothesis. J Nerv Ment Dis1994;182:591–2.
19.
SmelsonDAKauneMKindJLosonczyMF. The efficacy of olanzapine versus haloperidol in decreasing cue-elicited craving and relapse in withdrawn cocaine dependent schizophrenics. Presented at the National Institute of Drug Abuse New Clinical Drug Evaluation Unit Conference in May 1999, Boca Raton (FL).
20.
SmelsonDARoyARoyM.Risperidone diminished cue-elicited craving in withdrawn cocaine dependent patients. Can J Psychiatry1997;42:984.
21.
RoyARoyMSmelsonDA. Risperidone, Erg and Cocaine Craving. American Journal of Addictions1998;1:90.
22.
de LeonJ. Smoking and vulnerability for schizophrenia. Schizophr Bull1996;22:405–9.
23.
VorisJElderISebastianP.A simple test of cocaine craving and related responses. J Clin Psychol1991;47:320–3.
24.
KaySAOplerLFiszbeinA.Positive and Negative Syndrome Scale manual. Toronto (ON): Multi-Health Systems; 1992.
25.
BrownRAMontiPMMyersMGMartinRARivinusTDubreuliME, and others. Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry1998;155:220–5.
26.
SchmitzJMSlottsALAverillPMRothfleishSEBailleySTSayreSL, and others. Cocaine dependence with and without comorbid depression: A comparison of patient characteristics. Drug Alcohol Depend2000;60:189–98.
27.
KeckPEStrakowskiSMMcElroySL. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J Clin Psychiatry2000;61(3):4–9.
28.
FarrenCKHameediFARosenMAWoodsSJatlowDKostenTR. Significant interaction between clozapine and cocaine in cocaine addicts. Drug Alcohol Depend2000;59:153–63.
29.
MueserKTBellackASBlanchardJJ. Comorbidity of schizophrenia and substance abuse: Implications for treatment. J Consult Clin Psychol1992;60:845–56.
